Serine Protease 3 Promotes Progression of Diffuse Large B-Cell Lymphoma and Serves As a Novel Prognostic Predictor

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2023 Jan 9

PMID 36618965

Authors

Liangda Zheng

Xianting Wang

Weizhi Zheng

Hui Huang

Affiliations

Soon will be listed here.

Abstract

Diffuse large B-cell lymphoma (DLBCL) ranks among the most prevalent malignancies of the lymphohematopoietic system in adults. The PRSS (Serine Protease) protein family members had been reported to be involved in carcinogenesis as well as tumor progression. Here, we aimed to explore the expression profile of PRSS3 in DLBCL and investigate its clinical significance as well as detailed functions. We retrospectively enrolled 155 DLBCL patients from our hospital and tested protein expression level of PRSS3 through immunohistochemical staining. Accordingly, PRSS3 was highly expressed in certain DLBCL tissues. Chi-square test revealed that higher PRSS3 expression was correlated with advanced Ann Arbor stage, elevated serum LDH level, and higher International Prognostic Index. Moreover, univariate and multivariate analyses confirmed that higher PRSS3 can act as an independent unfavorable prognostic predictor for DLBCL. Two human DLBCL cell lines, SUDHL10 and OCI-LY3, were subjected for knockdown assays, followed by phonotype tests including proliferation and invasion. According to the cellular experiments, PRSS3-knockdown resulted in impaired DLBCL proliferation in the two cell lines above. Taken together, PRSS3 is a novel prognostic factor for DLBCL, which functions by multiple signaling pathways.

Citing Articles

Rational Design of a Multi-epitope Vaccine Using Neoantigen Against Colorectal Cancer Through Structural Immunoinformatics and ML-Enabled Simulation Approach.

Bhattacharya M, Sarkar A, Wen Z, Wu Y, Chakraborty C Mol Biotechnol. 2024; .

PMID: 39190054 DOI: 10.1007/s12033-024-01242-2.

References

Tani T, Kawashima I, Mita K, Takiguchi Y . Nucleotide sequence of the human pancreatic trypsinogen III cDNA. Nucleic Acids Res. 1990; 18(6):1631. PMC: 330537. DOI: 10.1093/nar/18.6.1631. View

Li K, Zhu X, Liu H, Zhang S, Li X, Xiao N . NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma. Cell Death Dis. 2020; 11(5):335. PMC: 7206140. DOI: 10.1038/s41419-020-2549-2. View

Wang F, Hu Y, Feng Y, Guo Y, Liu Y, Mao Q . High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer. J Surg Oncol. 2019; 119(8):1108-1121. DOI: 10.1002/jso.25448. View

Zhang Q, Fan H, Zou Q, Liu H, Wan B, Zhu S . TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression. J Cell Mol Med. 2018; 22(7):3560-3571. PMC: 6010880. DOI: 10.1111/jcmm.13634. View

Xing C, Ye H, Wang W, Sun M, Zhang J, Zhao Z . Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression. Artif Cells Nanomed Biotechnol. 2019; 47(1):3920-3928. DOI: 10.1080/21691401.2019.1671856. View

Hockla A, Miller E, Salameh M, Copland J, Radisky D, Radisky E . PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer. Mol Cancer Res. 2012; 10(12):1555-66. PMC: 3531873. DOI: 10.1158/1541-7786.MCR-12-0314. View

Tan Z, Gao L, Wang Y, Yin H, Xi Y, Wu X . PRSS contributes to cetuximab resistance in colorectal cancer. Sci Adv. 2020; 6(1):eaax5576. PMC: 6938705. DOI: 10.1126/sciadv.aax5576. View

Sun C, Li M, Zhang L, Sun F, Chen H, Xu Y . IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma. Cell Death Dis. 2022; 13(6):572. PMC: 9237101. DOI: 10.1038/s41419-022-05021-2. View

Marsit C, Okpukpara C, Danaee H, Kelsey K . Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer. Mol Carcinog. 2005; 44(2):146-50. DOI: 10.1002/mc.20125. View

10.

Lin B, Zhou X, Lin S, Wang X, Zhang M, Cao B . Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma. J Mol Med (Berl). 2017; 95(11):1237-1249. PMC: 8171496. DOI: 10.1007/s00109-017-1578-5. View

11.

Salameh M, Soares A, Hockla A, Radisky D, Radisky E . The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity. Biochem J. 2011; 440(1):95-105. PMC: 3380622. DOI: 10.1042/BJ20110788. View

12.

Chandrashekar D, Karthikeyan S, Korla P, Patel H, Shovon A, Athar M . UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022; 25:18-27. PMC: 8788199. DOI: 10.1016/j.neo.2022.01.001. View

13.

Wang L, Li L . R-CHOP resistance in diffuse large B-cell lymphoma: biological and molecular mechanisms. Chin Med J (Engl). 2020; 134(3):253-260. PMC: 7846449. DOI: 10.1097/CM9.0000000000001294. View

14.

Kayode O, Huang Z, Soares A, Caulfield T, Dong Z, Bode A . Small molecule inhibitors of mesotrypsin from a structure-based docking screen. PLoS One. 2017; 12(5):e0176694. PMC: 5413004. DOI: 10.1371/journal.pone.0176694. View

15.

Tokola S, Kuitunen H, Turpeenniemi-Hujanen T, Kuittinen O . Significance of bulky mass and residual tumor-Treated with or without consolidative radiotherapy-To the risk of relapse in DLBCL patients. Cancer Med. 2020; 9(6):1966-1977. PMC: 7064117. DOI: 10.1002/cam4.2798. View

16.

Ma R, Ye X, Cheng H, Ma Y, Cui H, Chang X . PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Gynecol Oncol. 2015; 137(3):546-52. DOI: 10.1016/j.ygyno.2015.02.022. View

17.

Ghilardi C, Anastasia A, Avigni R, Lupi M, Giavazzi R, Bani M . PO-44 - Tissue factor pathway inhibitor-2 (TFPI-2) is cleaved by PRSS3: implication for tumor endothelial cells migration. Thromb Res. 2016; 140 Suppl 1:S192-3. DOI: 10.1016/S0049-3848(16)30177-3. View

18.

Lenz G, Wright G, Dave S, Xiao W, Powell J, Zhao H . Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008; 359(22):2313-23. PMC: 9103713. DOI: 10.1056/NEJMoa0802885. View

19.

Diederichs S, Bulk E, Steffen B, Ji P, Tickenbrock L, Lang K . S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res. 2004; 64(16):5564-9. DOI: 10.1158/0008-5472.CAN-04-2004. View

20.

Matthews J, Bhatt S, Patricelli M, Nomanbhoy T, Jiang X, Natkunam Y . Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma. Blood. 2016; 128(2):239-48. PMC: 4946202. DOI: 10.1182/blood-2016-02-696856. View